These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33151020)

  • 21. Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens.
    Zheng Y; Hughes MD; Lockman S; Benson CA; Hosseinipour MC; Campbell TB; Gulick RM; Daar ES; Sax PE; Riddler SA; Haubrich R; Salata RA; Currier JS
    Clin Infect Dis; 2014 Sep; 59(6):888-96. PubMed ID: 24842909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.
    El-Khatib Z; Ekstrom AM; Ledwaba J; Mohapi L; Laher F; Karstaedt A; Charalambous S; Petzold M; Katzenstein D; Morris L
    AIDS; 2010 Jul; 24(11):1679-87. PubMed ID: 20453629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Prevalence of Drug Resistance Mutations Among Patients Failing First-Line Antiretroviral Therapy and Predictors of Virological Response 24 Weeks After Switch to Second-Line Therapy in São Paulo State, Brazil.
    Matsuda EM; Coelho LPO; Romero GF; de Moraes MJ; Lopez-Lopes GIS; Morejon K; Campeas AE; Cabral GB; Brígido LFM
    AIDS Res Hum Retroviruses; 2018 Feb; 34(2):156-164. PubMed ID: 28969448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference.
    Giacomelli A; Lai A; Franzetti M; Maggiolo F; Di Giambenedetto S; Borghi V; Francisci D; Magnani G; Pecorari M; Monno L; Vicenti I; Lepore L; Lombardi F; Paolucci S; Rusconi S;
    Antiviral Res; 2019 Dec; 172():104635. PubMed ID: 31629714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
    Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
    BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children.
    Kityo C; Boerma RS; Sigaloff KCE; Kaudha E; Calis JCJ; Musiime V; Balinda S; Nakanjako R; Boender TS; Mugyenyi PN; Rinke de Wit TF
    J Antimicrob Chemother; 2017 Sep; 72(9):2587-2595. PubMed ID: 28673027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India.
    Salvi S; Raichur P; Kadam D; Sangle S; Gupte N; Nevrekar N; Patil S; Chavan A; Nimkar S; Marbaniang I; Mave V
    BMC Infect Dis; 2022 Dec; 22(1):951. PubMed ID: 36528762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.
    Boender TS; Kityo CM; Boerma RS; Hamers RL; Ondoa P; Wellington M; Siwale M; Nankya I; Kaudha E; Akanmu AS; Botes ME; Steegen K; Calis JC; Rinke de Wit TF; Sigaloff KC
    J Antimicrob Chemother; 2016 Oct; 71(10):2918-27. PubMed ID: 27342546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
    Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
    PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of PI resistance in patients failing second-line ART in Vietnam.
    Thao VP; Quang VM; Day JN; Chinh NT; Shikuma CM; Farrar J; Van Vinh Chau N; Thwaites GE; Dunstan SJ; Le T
    J Antimicrob Chemother; 2016 Mar; 71(3):762-74. PubMed ID: 26661398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
    Judd A; Lodwick R; Noguera-Julian A; Gibb DM; Butler K; Costagliola D; Sabin C; van Sighem A; Ledergerber B; Torti C; Mocroft A; Podzamczer D; Dorrucci M; De Wit S; Obel N; Dabis F; Cozzi-Lepri A; García F; Brockmeyer NH; Warszawski J; Gonzalez-Tome MI; Mussini C; Touloumi G; Zangerle R; Ghosn J; Castagna A; Fätkenheuer G; Stephan C; Meyer L; Campbell MA; Chene G; Phillips A;
    HIV Med; 2017 Mar; 18(3):171-180. PubMed ID: 27625109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study.
    Sudjaritruk T; Teeraananchai S; Kariminia A; Lapphra K; Kumarasamy N; Fong MS; Hansudewechakul R; Bunupuradah T; Ly PS; Nallusamy RA; Sohn AH; Sirisanthana V;
    J Int AIDS Soc; 2020 Jul; 23(7):e25550. PubMed ID: 32628816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study.
    Kan W; Teng T; Liang S; Ma Y; Tang H; Zuohela T; Sun G; He C; Wall KM; Marconi VC; Liao L; Leng X; Liu P; Ruan Y; Xing H; Shao Y
    BMJ Open; 2017 Sep; 7(9):e016012. PubMed ID: 28882911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda.
    Ndahimana Jd; Riedel DJ; Mwumvaneza M; Sebuhoro D; Uwimbabazi JC; Kubwimana M; Mugabo J; Mulindabigwi A; Kirk C; Kanters S; Forrest JI; Jagodzinski LL; Peel SA; Ribakare M; Redfield RR; Nsanzimana S
    Trop Med Int Health; 2016 Jul; 21(7):928-35. PubMed ID: 27125473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
    Lambert-Niclot S; George EC; Pozniak A; White E; Schwimmer C; Jessen H; Johnson M; Dunn D; Perno CF; Clotet B; Plettenberg A; Blaxhult A; Palmisano L; Wittkop L; Calvez V; Marcelin AG; Raffi F;
    J Antimicrob Chemother; 2016 Apr; 71(4):1056-62. PubMed ID: 26702926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria.
    Ndembi N; Murtala-Ibrahim F; Tola M; Jumare J; Aliyu A; Alabi P; Mensah C; Abimiku A; Quiñones-Mateu ME; Crowell TA; Rhee SY; Shafer RW; Gupta R; Blattner W; Charurat ME; Dakum P
    AIDS Res Ther; 2020 Nov; 17(1):64. PubMed ID: 33143751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.
    Ngo-Giang-Huong N; Wittkop L; Judd A; Reiss P; Goetghebuer T; Duiculescu D; Noguera-Julian A; Marczynska M; Giacquinto C; Ene L; Ramos JT; Cellerai C; Klimkait T; Brichard B; Valerius N; Sabin C; Teira R; Obel N; Stephan C; de Wit S; Thorne C; Gibb D; Schwimmer C; Campbell MA; Pillay D; Lallemant M;
    BMC Infect Dis; 2016 Nov; 16(1):654. PubMed ID: 27825316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon.
    Liégeois F; Vella C; Eymard-Duvernay S; Sica J; Makosso L; Mouinga-Ondémé A; Mongo AD; Boué V; Butel C; Peeters M; Gonzalez JP; Delaporte E; Rouet F
    J Int AIDS Soc; 2012 Nov; 15(2):17985. PubMed ID: 23199801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa.
    Manasa J; Lessells RJ; Skingsley A; Naidu KK; Newell ML; McGrath N; de Oliveira T;
    PLoS One; 2013; 8(8):e72152. PubMed ID: 23991055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand.
    European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group in EuroCoord
    Clin Infect Dis; 2018 Feb; 66(4):594-603. PubMed ID: 29029056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.